SFTCG would like to congratulate this year's oral and poster presentation award winners, who presented at the 2022 Annual Meeting in Lyon.
Oral Presentation Winners
Juliette Rosier, Université Bordeaux
CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells leading to imprinting defects
Celia Sourd, Genethon, UMR_S951, Inserm, Univ Evry, Université Paris Saclay, EPHE
An AAVpo1A1 vector expressing MTM1 corrects skeletal muscle pathology with detargeted liver transduction in myotubular myopathy mice
Tina Briolay, Université de Nantes
Development of a bio-inspired nanovector for targeted cancer gene therapy
Ugo Hirigoyen, Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA
Characterization of tumor extracellular vesicles produced during oncolytic infection
Poster Presentation Winners
Alejandra Gutierrez, CIRI; Inserm U1111, ENS Lyon, France
Chemically surface modified AAV6 vectors combined with nanoblades are a promising alternative for gene knock-in in HSCs
Mathilde Beaufils, Univ. Grenoble Alpes Inserm U1216 CHU Grenoble Alpes Grenoble Institut Neurosciences
Development of knock-out muscle cell line using lentivirus-mediated CRISPR/Cas 9 gene editing: application to RYR1 gene
Guillaume Wurtz, Universite Paris Sud; Université Sorbonne Paris Cité; Institut du Cerveau et de la Moelle épiniere; Inserm Modulation of cholesterol metabolism as a new therapeutical approach for amyotrophic lateral sclerosis
Comentários